prednisolone has been researched along with Bronchopulmonary Dysplasia in 5 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Preterm infants who received ≥30 days of prednisolone or methylprednisolone for treatment of respiratory complications following preterm birth." | 8.02 | Respiratory effects of prolonged prednisolone use in infants with evolving and established Bronchopulmonary dysplasia. ( Liviskie, C; McPherson, C; Rao, R; Vesoulis, Z; Zeller, B, 2021) |
| "There are few published data on the efficacy and safety of prednisolone in preterm infants with bronchopulmonary dysplasia (BPD)." | 7.91 | Extended course of prednisolone in infants with severe bronchopulmonary dysplasia. ( Cuna, A; Linafelter, A; Liu, C; Oschman, A; Quigley, A; Sampath, V; Truog, WE, 2019) |
| "The purpose of this work was to determine whether oral prednisolone is effective in weaning infants with bronchopulmonary dysplasia, after 36 weeks' postmenstrual age, off supplemental oxygen and to identify factors associated with successful weaning." | 7.74 | Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia. ( Bhandari, A; Hussain, N; Kimble, C; Pappagallo, M; Schramm, CM, 2008) |
| "Preterm infants who received ≥30 days of prednisolone or methylprednisolone for treatment of respiratory complications following preterm birth." | 4.02 | Respiratory effects of prolonged prednisolone use in infants with evolving and established Bronchopulmonary dysplasia. ( Liviskie, C; McPherson, C; Rao, R; Vesoulis, Z; Zeller, B, 2021) |
| "In 1999, 80% of French neonatal centers used corticosteroids, mainly betamethasone (BMT), to prevent or treat bronchopulmonary dysplasia (BPD) [Lee SK, McMillan DD, Ohlson A, et al." | 3.75 | [Glucocorticoide therapy in premature infants: French practices in 2006]. ( Alberti, C; Aujard, Y; Autret-Leca, E; Baud, O; Bauer, S; Bensouda-Grimaldi, L; Jonville-Béra, AP, 2009) |
| "The purpose of this work was to determine whether oral prednisolone is effective in weaning infants with bronchopulmonary dysplasia, after 36 weeks' postmenstrual age, off supplemental oxygen and to identify factors associated with successful weaning." | 3.74 | Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia. ( Bhandari, A; Hussain, N; Kimble, C; Pappagallo, M; Schramm, CM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liviskie, C | 1 |
| Vesoulis, Z | 1 |
| Zeller, B | 1 |
| Rao, R | 1 |
| McPherson, C | 1 |
| Linafelter, A | 1 |
| Cuna, A | 1 |
| Liu, C | 1 |
| Quigley, A | 1 |
| Truog, WE | 1 |
| Sampath, V | 1 |
| Oschman, A | 1 |
| Jensen, EA | 1 |
| White, AM | 1 |
| Liu, P | 1 |
| Yee, K | 1 |
| Waber, B | 1 |
| Monk, HM | 1 |
| Zhang, H | 1 |
| Autret-Leca, E | 1 |
| Bauer, S | 1 |
| Alberti, C | 1 |
| Jonville-Béra, AP | 1 |
| Aujard, Y | 1 |
| Bensouda-Grimaldi, L | 1 |
| Baud, O | 1 |
| Bhandari, A | 1 |
| Schramm, CM | 1 |
| Kimble, C | 1 |
| Pappagallo, M | 1 |
| Hussain, N | 1 |
5 other studies available for prednisolone and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Respiratory effects of prolonged prednisolone use in infants with evolving and established Bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Pre | 2021 |
Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Child Development; Female; Glucocorticoids; Humans; Infant, Extremely Pr | 2019 |
Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
Topics: Birth Weight; Bone Diseases, Metabolic; Bronchopulmonary Dysplasia; Comorbidity; Female; Furosemide; | 2016 |
[Glucocorticoide therapy in premature infants: French practices in 2006].
Topics: Administration, Inhalation; Anti-Inflammatory Agents; Betamethasone; Bronchopulmonary Dysplasia; Bud | 2009 |
Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia.
Topics: Administration, Oral; Birth Weight; Bronchopulmonary Dysplasia; Carbon Dioxide; Female; Gestational | 2008 |